Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
178.27B
Market cap178.27B
Price-Earnings ratio
27.40
Price-Earnings ratio27.40
Dividend yield
2.36%
Dividend yield2.36%
Average volume
16.64M
Average volume16.64M
High today
$103.19
High today$103.19
Low today
$100.88
Low today$100.88
Open price
$102.52
Open price$102.52
Volume
12.44M
Volume12.44M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$100.88
52 Week low$100.88

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $102.80. The company's market cap stands at 178.27B, with a P/E ratio of 27.40 and a dividend yield of 2.4%.

On 2026-03-31, Abbott(ABT) stock moved within a range of $100.88 to $103.19. With shares now at $102.80, the stock is trading +1.9% above its intraday low and -0.4% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 12.44M, versus its average volume of 16.64M.

The stock's 52-week range extends from a low of $100.88 to a high of $139.06.

The stock's 52-week range extends from a low of $100.88 to a high of $139.06.

ABT News

Simply Wall St 10h
Abbott Oncology Integration Into OncoEMR Tests Long Term Growth Story

Abbott Laboratories is integrating its Precision Oncology portfolio into Flatiron Health's OncoEMR platform used by a wide U.S. oncology network. The move brin...

Abbott Oncology Integration Into OncoEMR Tests Long Term Growth Story
TipRanks 14h
Abbott price target lowered to $131 from $140 at BTIG

BTIG lowered the firm’s price target on Abbott (ABT) to $131 from $140 and keeps a Buy rating on the shares. The firm is updating its model for Abbott Labs to i...

TipRanks 2d
Abbott integrates Precision Oncology portfolio into Flatiron’s OncoEMR

Abbott (ABT) and Flatiron Health announced the integration of Abbott’s comprehensive Precision Oncology portfolio into OncoEMR, Flatiron’s cloud-based Electroni...

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
25.8%
Sell
0%

More ABT News

Simply Wall St 2d
Is Abbott Laboratories Offering Value After Recent Share Price Weakness?

Wondering if Abbott Laboratories at around US$103.99 is priced for opportunity or risk? This article focuses squarely on what the current share price might be i...

Is Abbott Laboratories Offering Value After Recent Share Price Weakness?
Simply Wall St 4d
Abbott Culture Alignment Supports Long Term Execution And Valuation Story

Abbott Laboratories (NYSE:ABT) executives outlined how pandemic-era coordination across office, manufacturing, and sales teams has shaped the company’s current...

Abbott Culture Alignment Supports Long Term Execution And Valuation Story
TipRanks 4d
This Leading Pharma Company Has Grown Its Dividend 70% Since 2020

Investors on the hunt for a fast-growing dividend need look no further than Abbott Laboratories (ABT). Claim 30% Off TipRanks Premium Unlock hedge fund-level da...

Simply Wall St 5d
What Abbott Laboratories's Cancer Screening Deal and Libre Data Reveal About Its Chronic Care Ambitions

In March 2026, Abbott Laboratories completed its roughly US$23.00 billion acquisition of Exact Sciences, adding the Cologuard colorectal cancer screening test a...

What Abbott Laboratories's Cancer Screening Deal and Libre Data Reveal About Its Chronic Care Ambitions

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.